Atricure reports third quarter 2023 financial results

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management and post-operative pain management, today announced third quarter 2023 financial results. “we are excited to report another strong quarter at atricure, driven by the performance across our business globally. we also made progress against many strategic initiatives in our pillars of innovation, education and c.
ATRC Ratings Summary
ATRC Quant Ranking